Share-based Compensation (Tables)

12 Months Ended

Jun. 30, 2014

Share-based Compensation

Schedule of weighted average assumptions used to estimate fair values of the stock options granted and the estimated annual forfeiture rates used to recognize the associated compensation expense

	June 30,  2014		June 30, 2013		June 30, 2012
Risk-free interest rate	2.1	%	1.0	%	1.1	%
Expected volatility	62.8	%	61.6	%	63.5	%
Expected dividend yield	0.0	%	0.0	%	0.0	%
Forfeiture rate	7.5	%	7.5	%	7.5	%
Expected term (in years)	5.9 years		6.1 years		5.2 years
Weighted average fair value	$8.55		$2.53		$2.03

Summary of stock option award activity

							Weighted
			Weighted-				Average
			Average		Aggregate		Remaining
			Exercise		Intrinsic		Contractual
(In thousands, except for weighted average price and life data)	Awards		Price		Value		Life (yrs.)
Outstanding at July 1, 2011	1,946		$	7.57
Granted	852		3.74
Exercised	(8	)	3.21		$	7
Forfeited, expired or repurchased	(43	)	5.59
Outstanding at June 30, 2012	2,747		6.42
Granted	565		4.30
Exercised	(511	)	5.44		$	1,825
Forfeited, expired or repurchased	(482	)	8.39
Outstanding at June 30, 2013	2,319		5.71
Granted	780		13.90
Exercised	(783	)	6.41		$	24,375
Forfeited, expired or repurchased	(111	)	6.49
Outstanding at June 30, 2014	2,205		$	7.84	$	92,119	7.4
Vested and expected to vest at June 30, 2014	2,115		$	7.69	$	88,682	7.3
Exercisable at June 30, 2014	854		$	4.97	$	38,132	5.5

Summary of restricted stock awards

(In thousands)	Awards		Weighted Average Grant - date Fair Value		Aggregate Intrinsic Value
Non-vested at July 1, 2011	155		$	6.94
Granted	35		3.62
Vested	(113	)	5.91		$	459
Forfeited	(3	)	6.94
Non-vested at June 30, 2012	74		6.94
Granted	38		5.06
Vested	(110	)	6.30		$	491
Forfeited	(2	)	6.94
Non-vested at June 30, 2013	—		—
Granted	269		24.07
Vested	(252	)	23.45		$	10,440
Forfeited	(1	)	24.48
Non-vested at June 30, 2014	16		$	34.01

Schedule of allocation of share-based compensation costs recognized in the Consolidated Statements of Operations by financial statement line item

	For Fiscal Year Ended June 30,
(In thousands)	2014		2013		2012
Selling, general and administrative	$	7,388	$	1,206	$	1,619
Research and development	675		99		252
Cost of sales	963		172		291
Total	$	9,026	$	1,477	$	2,162
Tax benefit at statutory rate	$	3,375	$	169	$	138